Stereotactic body radiation therapy for early-stage non-small-cell lung cancer

Expert Review of Anticancer Therapy

Volumn 8, Issue 1, 2008, Pages 87-98

  Lo, Simon S ^a,g   Fakiris, Achilles J ^b,c   Papiez, Lech ^d   Abdulrahman, Ramzi ^d   McGarry, Ronald C ^e   Henderson, Mark A ^b   Forquer, Jeffrey A ^b   Hoopes, David ^f   Timmerman, Robert D ^d  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^c Department of Radiation Oncology ^*  (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

^f WRIGHT PATTERSON AIR FORCE BASE   (United States)

^g OHIO STATE UNIVERSITY   (United States)

Author keywords

Early stage; Lung cancer; Stereotactic body radiation therapy

Indexed keywords

FLUORODEOXYGLUCOSE;

BRONCHITIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; DOSIMETRY; EARLY CANCER; EXPERIENCE; FATIGUE; FOLLOW UP; HUMAN; HYPOXIA; LUNG NON SMALL CELL CANCER; MUSCULOSKELETAL DISEASE; PERICARDIAL EFFUSION; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; RADIATION DERMATITIS; RADIATION DOSE; RADIATION PHYSICS; RADIATION PNEUMONIA; RADIOBIOLOGY; RETROSPECTIVE STUDY; REVIEW; TRACHEA STENOSIS; TREATMENT PLANNING; WHOLE BODY RADIATION; LUNG TUMOR; STEREOTACTIC PROCEDURE;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; STEREOTAXIC TECHNIQUES;

EID: 38349071621     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/14737140.8.1.87     Document Type: Review

References (59)

1. Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L. Stereotactic body radiation therapy in multiple organ sites. J. Clin. Oncol. 25(8), 947-952 (2007).
2. Mountain CE A new international staging system for lung cancer. Chest 89(4 Suppl.), S225-S233 (1986).
3. Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J. Thorac. Cardiovasc. Surg. 96(3), 440-447 (1988).
4. McGarry RC, Song G, des Rosiers P, Timmerman R. Observation-only management of early stage, medically inoperable lung cancer: poor outcome. Chest 121 (4), 1155-1158 (2002).
5. Armstrong JG, Minsky BD. Radiation therapy for medically inoperable stage I and II non-small cell lung cancer. Cancer Treat. Rev. 16(4), 247-255 (1989).
6. Coy P, Kennelly GM. The role of curative radiotherapy in the treatment of lung cancer. Cancer 45 (4), 698-702 (1980).
7. Haffy BG, Goldberg NB, Gerstley J, Fischer DB, Peschel RE. Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 15(1), 69-73 (1988).
8. Kaskowitz L, Graham MV, Emami B, Halverson KJ, Rush C. Radiation therapy alone for stage I non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 27(3), 517-523 (1993).
9. Dosoretz DE, Katin MJ, Blitzer PH et al. Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies. Int. J. Radiat. Oncol. Biol. Phys. 24(1), 3-9 (1992).
10. Dosoretz DE, Galmarini D, Rubenstein JH et al. Local control in medically inoperable lung cancer: an analysis of its importance in outcome and factors determining the probability of tumor eradication. Int. J. Radiat. Oncol. Biol. Phys. 27(3), 507-516 (1993).
11. Dosoretz DE, Katin MJ, Blitzer PH et al. Medically inoperable lung carcinoma: the role of radiation therapy. Semin. Radiat. Oncol. 6(2), 98-104 (1996).
12. Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int. J. Radiat. Oncol Biol. Phys. 40(1), 149-154 (1998).
13. Willner J, Baier K, Caragiani E, Tschammler A, Flentje M. Dose volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 52(2), 382-389 (2002).
14. Marrel MK, Ten Haken RK, Hazuka MB et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer 24(1), 31-37 (1999).
15. Bradley J, Graham MV, Winter K et al. Toxicity and outcome results of RTOG 9311: a Phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 61(2), 318-328 (2005).
16. Timmerman R, Papiez L, McGarry R et al. Extracranial stereotactic radioablation: results of a Phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124(5), 1946-1955 (2003).
17. McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int. J. Radiat. Oncol. Biol. Phys. 63(4), 1010-1015 (2005).
18. Timmerman R, McGarry R, Yiannoutsos C et al. Excessive toxicity when treating central tumors in a Phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J. Clin. Oncol. 24(30), 4833-4839 (2006).
19. Nagata Y, Takayama K, Matsuo Y et al. Clinical outcomes ofa phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int. J. Radiat. Oncol. Biol. Phys. 63(5), 1427-1431 (2005).
20. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br. J. Radiol. 62(740), 679-694 (1989).
21. Guerrero M, Li XA. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy Phys. Med. Biol. 49(20), 4825-4835 (2004).
22. Timmerman RD, Park C, Kavanagh BD. The North American experience with stereotactic body radiation therapy in non-small cell lung cancer. J. Thorac. Oncol. 2 (7 Suppl. 3); S101-S112 (2007).
23. Benedict SH, Lin PS, Zwicker RD, Huang DT, Schmidt-Ullrich RK. The biological effectiveness of intermittent irradiation as a function of overall treatment time: development of correction factors for linac-based stereotactic radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 37(4), 765-769 (1997).
24. Fowler JF, Welsh JS, Howard SP. Loss of biological effect in prolonged fraction delivery. Int. J. Radiat. Oncol. Biol. Phys. 59(1), 242-249 (2004).
25. Wolbarst AB, Chin LM, Svensson GK. Optimization of radiation therapy: integral-response of a model biological system. Int. J. Radiat. Oncol. Biol. Phys. 8(10), 1761-1769 (1982).
26. Wulf J, Hadinger U, Oppitz U, Olshausen B, Flentje M. Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame. Radiother. Oncol. 57(2), 225-236 (2000).
27. Herfarth KK, Debus J, Lohr F et al. Extracranial stereotactic radiation therapy: set-up accuracy of patients treated for liver metastases. Int. J. Radiat. Oncol. Biol. Phys. 46(2), 329-335 (2000).
28. Negoro Y, Nagata Y, Aoki T et al. The effectiveness of an immobilization device in conformal radiotherapy for lung tumor: reduction of respiratory tumor movement and evaluation of the daily setup accuracy. Int. J. Radiat. Oncol. Biol. Phys. 50(4), 889-898 (2001).
29. Kimura T, Hirokawa Y, Murakami Y et al. Reproducibility of organ position using voluntary breath-hold method with spirometer for extracranial stereotactic radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 60(4), 1307-1313 (2004).
30. Murphy MJ, Martin D, Whyte R, Hai J, Ozhasoglu C, Le QT. The effectiveness of breath-holding to stabilize lung and pancreas tumors during radiosurgery. Int. J. Radiat. Oncol. Biol. Phys. 53(2), 475-482 (2002).
31. Wang LT, Solberg TD, Medin PM, Boone R. Infrared patient positioning for stereotactic radiosurgery of extracranial tumors. Comput. Biol. Med. 31(2), 101-111 (2001).
32. Vedam SS, Keall PJ, Kini VR, Mohan R. Determining parameters for respirationgated radiotherapy. Med. Phys. 28(10), 2139-2146 (2001).
33. Shirato H, Shimizu S, Shimizu T, Nishioka T, Miyasaka F. Real-time tumour-tracking radiotherapy. Lancet 353(9161), 1331-1332 (1999).
34. Kuriyama K, Onishi H, Sano N et al. A new irradiation unit constructed of self-moving gantry-CT and linac. Int. J. Radiat. Oncol. Biol. Phys. 55(2), 428-435 (2003).
35. Schweikard A, Shiomi H, Adler J. Respiration tracking in radiosurgery. Med. Phys. 31(10), 2738-2741 (2004).
36. Timmerman RD, Kavanagh BD. Stereotactic body radiation therapy. Curr. Probl. Cancer 29(3), 120-157 (2005).
37. Haedinger U, Krieger T, Flentje M, Wulf J. Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets. Int. J. Radiat. Oncol. Biol. Phys. 61(1), 239-249 (2005).
38. Underberg RW, Lagerwaard FJ, Cuijpers JP, Slotman BJ, van Sornsen de Koste JR, Senan S. Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 60(4), 1283-1290 (2004).
39. Guckenberger M, Wilbert J, Krieger T et al. Four-dimensional treatment planning for stereotactic body radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 69(1), 276-285 (2007).
40. Wang L, Feigenberg S, Chen L, Pasklev K, Ma CC. Benefit of three-dimensional image-guided stereotactic localization in the hypofractionated treatment of lung cancer. Int. J. Radiat, Oncol. Biol. Phys. 66(3), 738-747 (2006).
41. Guckenberger M, Meyer J, Wilbert J et al. Intra-fractional uncertainties in cone-beam CT based image-guided radiotherapy (IGRT) of pulmonary tumors. Radiother Oncol. 83(1), 57-64 (2007).
42. Guckenberger M, Meyer J, Wilbert J et al. Cone-beam CT based image-guidance for extracranial stereotactic radiotherapy of intrapulmonary tumors. Acta Oncol. 45(7), 897-906 (2006).
43. Shirato H. Shimizu S, Kitamura K, Onimaru R. Organ motion in image-guided radiotherapy: lessons from real-time tumor-tracking radiotherapy. Int. J. Clin. Oncol. 12(1), 8-16 (2007).
44. Wulf J, Hadinger U, Oppitz U, Thiele W, Flentje M. Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liver. Radiother. Oncol. 66(2), 141-150 (2003).
45. Blomgren H Lax I, Goranson H et al. Radiosurgery for tumors in the body: clinical experience using a new method. J. Radiosurg. 1(1), 63-74 (1998).
46. Uematsu M, Shioda A, Tahara K et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer 82(6), 1062-1070 (1998).
47. Uemarsu M, Shioda A, Suda A et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int. J. Radiat. Oncol. Biol. Phys. 51(3), 666-670 (2001).
48. Nagara Y, Negoro Y, Aoki T et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int. J. Radiat. Oncol Biol. Phys. 52(4), 1041-1046 (2002).
49. Xia T, Li H, Sun Q et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/ II non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 66(1), 117-125 (2006).
50. Zimmermann FB, Geinitz H, Schill S et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 48(1), 107-114 (2005).
51. Zimmermann FB, Geinitz H, Schill S et al. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Acta Oncol. 45(7), 796-801 (2006).
52. Nyman J, Johansson KA, Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer - mature results for medically inoperable patients. Lung Cancer 51(1), 97-103 (2006).
53. Onishi H, Araki T, Shirato H et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101(7), 1623-1631 (2004).
54. Baumann P, Nyman J, Lax I et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analvsis of patients treated in the Nordic countries. Acta Oncol. 45(7), 787-795 (2006).
55. Hoyer M, Roed H, Hansen AT et al. Prospective study on stereotactic radiotherapy of limited stage non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 66 (4 Suppl.), S128-S135 (2006).
56. Sinha B, McGarry RC. Stereotactic body radiotherapy for bilateral primary lung cancers: the Indiana University experience. Int. J. Radiat. Oncol. Biol. Phys. 66(4), 1120-1124 (2006).
57. Hoopes DJ, Tann M, Fletcher JW et al. FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer. Lung Cancer 56(2), 229-234 (2007).
58. Hoopes DJ, Fletcher J, Tann M et al. A prospective trial of serial FDG-PET in patients with medically inoperable stage I non-small cell lung cancer treated with hypofractioanted stereotactic body radiotherapy (SBRT). Int. J. Radiat. Oncol. Biol. Phys. 66(4 Suppl.), S26-S27 (2006).
59. Hof H, Muenter M, Oetzel, Hoess A, Debus J, Herfarth K. Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC). Cancer 110(1), 148-155 (2007).